Saturated fatty acids as possible important metabolites for epithelial ovarian cancer based on the free and esterified fatty acid profiles determined by GC-MS analysis

Jemal A. , Siegel R. , Xu J. and Ward E. , Cancer statistics, 2010, CA Cancer J Clin 60 (2010), 277-300.

Odunsi K. , Wollman R.M. , Ambrosone C.B. , Hutson A. , McCann S.E. , Tammela J. , Geisler J.P. , Miller G. , Sellers T. , Cliby W. , Qian F. , Keitz B. , Intengan M. , Lele S. and Alderfer J.L. , Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics, Int J Cancer 113 (2005), 782-8.

Petricoin E.F. , Ardekani A.M. , Hitt B.A. , Levine P.J. , Fusaro V.A. , Steinberg S.M. , Mills G.B. , Simone C. , Fishman D.A. , Kohn E.C. and Liotta L.A. , Use of proteomic patterns in serum to identify ovarian cancer, Lancet 359 (2002), 572-7.

Claudino W.M. , Quattrone A. , Biganzoli L. , Pestrin M. , Bertini I. and Di Leo A. , Metabolomics: available results, current research projects in breast cancer, and future applications, J Clin Oncol 25 (2007), 2840-6.

Spratlin J.L. , Serkova N.J. and Eckhardt S.G. , Clinical applications of metabolomics in oncology: a review, Clin Cancer Res 15 (2009), 431-40.

Qiu Y. , Cai G. , Su M. , Chen T. , Zheng X. , Xu Y. , Ni Y. , Zhao A. , Xu L.X. , Cai S. and Jia W. , Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS, J Proteome Res 8 (2009), 4844-50.

Zhou J. , Xu B. , Huang J. , Jia X. , Xue J. , Shi X. , Xiao L. and Li W. , 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma, Clin Chim Acta 401 (2009), 8-13.

Sreekumar A. , Poisson L.M. , Rajendiran T.M. , Khan A.P. , Cao Q. , Yu J. , Laxman B. , Mehra R. , Lonigro R.J. , Li Y. , Nyati M.K. , Ahsan A. , Kalyana-Sundaram S. , Han B. , Cao X. , Byun J. , Omenn G.S. , Ghosh D. , Pennathur S. , Alexander D.C. , Berger A. , Shuster J.R. , Wei J.T. , Varambally S. , Beecher C. and Chinnaiyan A.M. , Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression, Nature 457 (2009), 910-4.

Chen J. , Zhang X. , Cao R. , Lu X. , Zhao S. , Fekete A. , Huang Q. , Schmitt-Kopplin P. , Wang Y. , Xu Z. , Wan X. , Wu X. , Zhao N. , Xu C. and Xu G. , Serum 27-nor-5beta-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer, J Proteome Res 10 (2011), 2625-32.

Woo H.M. , Kim K.M. , Choi M.H. , Jung B.H. , Lee J. , Kong G. , Nam S.J. , Kim S. , Bai S.W. and Chung B.C. , Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers, Clin Chim Acta 400 (2009), 63-9.

Okita M. , Gaudette D.C. , Mills G.B. and Holub B.J. , Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients, Int J Cancer 71 (1997), 31-4.

Shen Z. , Wu M. , Elson P. , Kennedy A.W. , Belinso J. , Casey G. and Xu Y. , Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases, Gynecol Oncol 83 (2001), 25-30.

Yi L. , He J. , Liang Y. , Yuan D. , Gao H. and Zhou H. , Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients, Chem Phys Lipids 150 (2007), 204-16.

Johansson E. , Kettaneh-Wold N. , Trygg J. , Wikstrom C. and Wold S. , Multi- and Megavariate Data Analysis, part 1, Basic principles and applications, Umetrics AB, Sweden, 2006.

Gika H.G. , Macpherson E. , Theodoridis G.A. and Wilson I.D. , Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples, J Chromatogr B Analyt Technol Biomed Life Sci 871 (2008), 299-305.

Gika H.G. , Theodoridis G.A. , Wingate J.E. and Wilson I.D. , Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: Application to human urine, J Proteome Res 6 (2007), 3291-303.

Teneriello M.G. and Park R.C. , Early detection of ovarian cancer, CA Cancer J Clin 45 (1995), 71-87.

Zhang T. , Wu X. , Yin M. , Fan L. , Zhang H. , Zhao F. , Zhang W. , Ke C. , Zhang G. , Hou Y. , Zhou X. , Lou G. and Li K. , Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry, Clin Chim Acta 413 (2012), 861-8.

Garcia E. , Andrews C. , Hua J. , Kim H.L. , Sukumaran D.K. , Szyperski T. and Odunsi K. , Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe, J Proteome Res 10 (2011), 1765-71.

Wang D.C. , Sun C.H. , Liu L.Y. , Sun X.H. , Jin X.W. , Song W.L. , Liu X.Q. and Wan X.L. , Serum fatty acid profiles using GC-MS and multivariate statistical analysis: Potential biomarkers of Alzheimer's disease, Neurobiol Aging 33 (2012), 1057-66.

Gercel-Taylor C. , Doering D.L. , Kraemer F.B. and Taylor D.D. , Aberrations in normal systemic lipid metabolism in ovarian cancer patients, Gynecol Oncol 60 (1996), 35-41.

Genkinger J.M. , Hunter D.J. , Spiegelman D. , Anderson K.E. , Beeson W.L. , Buring J.E. , Colditz G.A. , Fraser G.E. , Freudenheim J.L. , Goldbohm R.A. , Hankinson S.E. , Koenig K.L. , Larsson S.C. , Leitzmann M. , McCullough M.L. , Miller A.B. , Rodriguez C. , Rohan T.E. , Ross J.A. , Schatzkin A. , Schouten L.J. , Smit E. , Willett W.C. , Wolk A. , Zeleniuch-Jacquotte A. , Zhang S.M. and Smith-Warner S.A. , A pooled analysis of 12 cohort studies of dietary fat, cholesterol and egg intake and ovarian cancer, Cancer Causes Control 17 (2006), 273-85.

Merritt M.A. , Cramer D.W. , Missmer S.A. , Vitonis A.F. , Titus L.J. and Terry K.L. , Dietary fat intake and risk of epithelial ovarian cancer by tumour histology, Br J Cancer 110 (2014), 1392-401.

Sharma A. , Belna J. , Espat J. , Rodriguez G. , Cannon V.T. and Hurteau J.A. , Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer, Am J Obstet Gynecol 200 (2009), 516 e1-6.

Ansenberger K. , Richards C. , Zhuge Y. , Barua A. , Bahr J.M. , Luborsky J.L. and Hales D.B. , Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 year, Gynecol Oncol 117 (2010), 341-7.

Sutphen R. , Xu Y. , Wilbanks G.D. , Fiorica J. , Grendys, Jr. E.C. , LaPolla J.P. , Arango H. , Hoffman M.S. , Martino M. , Wakeley K. , Griffin D. , Blanco R.W. , Cantor A.B. , Xiao Y.J. and Krischer J.P. , Lysophospholipids are potential biomarkers of ovarian cancer, Cancer Epidemiol Biomarkers Prev 13 (2004), 1185-91.

Baker D.L. , Morrison P. , Miller B. , Riely C.A. , Tolley B. , Westermann A.M. , Bonfrer J.M. , Bais E. , Moolenaar W.H. and Tigyi G. , Plasma lysophosphatidic acid concentration and ovarian cancer, JAMA 287 (2002), 3081-2.

Xu Y. , Shen Z. , Wiper D.W. , Wu M. , Morton R.E. , Elson P. , Kennedy A.W. , Belinson J. , Markman M. and Casey G. , Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers, JAMA 280 (1998), 719-23.

Gansler T.S. , Hardman, 3rd W. , Hunt D.A. , Schaffel S. and R.A. Hennigar , Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival, Hum Pathol 28 (1997), 686-92.

Alo P.L. , Visca P. , Framarino M.L. , Botti C. , Monaco S. , Sebastiani V. , Serpieri D.E. and Di Tondo U. , Immunohistochemical study of fatty acid synthase in ovarian neoplasms, Oncol Rep 7 (2000), 1383-8.

Ruddock M.W. , Stein A. , Landaker E. , Park J. , Cooksey R.C. , McClain D. and Patti M.E. , Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling, J Biochem 144 (2008), 599-607.

Liu Y. , Chen Y. , Momin A. , Shaner R. , Wang E. , Bowen N.J. , Matyunina L.V. , Walker L.D. , McDonald J.F. , Sullards M.C. and Merrill, Jr. A.H. , Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry, Mol Cancer 9 (2010), 186.